Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2017 | A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio | Chien, MH; Lee, WJ; Chang, YC; Chang, WM; Lai, TC; Chan, DV; Sharma, R; Lin, YF; Hsiao, M | Molecular Cancer Therapeutics 16(6), 1102-1113 |